Education
About Us
Working with TipRanks
Follow Us
Dynatronics (DYNT)
:DYNT
Top Page
Dynatronics
(OTC:DYNT)
46Neutral
Dynatronics (DYNT) vs. S&P 500 (SPY)
Market Cap
$933.89K
Dividend YieldN/A
Average Volume (3M)5.02K
Price to Earnings (P/E)―
Beta (1Y)-0.64
Revenue Growth-14.91%
EPS Growth49.03%
CountryUS
Employees111
SectorHealthcare
Sector Strength62
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.56
Shares Outstanding8,810,332
10 Day Avg. Volume6,309
30 Day Avg. Volume5,022
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.04
Price to Cash Flow (P/CF)2.10
P/FCF Ratio1.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Dynatronics Business Overview & Revenue Model
Company DescriptionDynatronics Corporation (DYNT) is a medical device company that specializes in the design, manufacture, and distribution of advanced rehabilitation and physical therapy products. The company operates within the healthcare sector, focusing on providing innovative solutions that aid in patient recovery and enhance therapeutic outcomes. Its core product offerings include electrotherapy devices, therapeutic ultrasound products, and treatment tables, among others.
How the Company Makes MoneyDynatronics generates revenue primarily through the sale of its medical devices and rehabilitation equipment to various healthcare providers, including hospitals, clinics, and physical therapy centers. The company employs a direct sales force, distributors, and online platforms to market its products across different regions. Additionally, Dynatronics may engage in strategic partnerships with distributors and healthcare organizations to expand its market reach and enhance product visibility. The company's revenue streams are significantly influenced by the demand for rehabilitation equipment and technological advancements in the healthcare sector.
Dynatronics Financial Statement Overview
Summary
Dynatronics faces significant challenges in revenue growth and profitability, as reflected in the income statement. While the balance sheet shows a moderate debt position, declining equity raises concerns about long-term sustainability. The cash flow situation highlights the company's struggle to generate consistent positive cash flows, which could restrict future investment and growth opportunities. Strategic improvements are necessary to enhance financial performance in the competitive medical equipment & supplies industry.Income Statement
Dynatronics has experienced declining revenues over the past years, with the TTM revenue showing a significant decrease from previous periods. The gross profit margin has also decreased, indicating potential cost management issues. The company continues to report negative EBIT and net income, reflecting ongoing profitability challenges. Despite these issues, the company has managed to improve its EBITDA margin slightly in recent periods.45
Neutral
Balance Sheet
The balance sheet shows a moderate debt-to-equity ratio, indicating a balanced capital structure. However, stockholders' equity has been declining, which could signal eroding shareholder value. The equity ratio remains stable, yet there's a noticeable decrease in total assets over recent years, which may impact the company's growth potential.55
Neutral
Cash Flow
The cash flow statement reveals inconsistent operating cash flows, with the latest TTM showing a slight positive shift. Despite this, free cash flow remains low, reflecting limited cash generation after capital expenditures. The company has managed to slightly improve its cash position compared to the previous year, but challenges in sustaining positive cash flows persist.50
Neutral
| Breakdown | |||||
| TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 29.93M | 32.53M | 40.61M | 44.34M | 47.80M | 53.41M | Gross Profit |
| 7.13M | 7.63M | 10.15M | 10.67M | 12.89M | 15.10M | EBIT |
| -2.05M | -2.27M | -4.85M | -4.76M | -3.76M | -2.99M | EBITDA |
| -1.09M | -976.01K | -3.50M | -3.33M | -2.28M | -1.26M | Net Income Common Stockholders |
| -2.87M | -2.70M | -5.66M | -4.73M | 1.21M | -4.32M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 791.01K | 483.92K | 553.00K | 701.00K | 6.25M | 2.32M | Total Assets |
| 25.77M | 25.94M | 30.06M | 35.43M | 39.14M | 27.57M | Total Debt |
| 6.68M | 6.69M | 5.65M | 3.84M | 5.08M | 1.01M | Net Debt |
| 5.89M | 6.20M | 5.10M | 3.14M | -1.17M | -1.30M | Total Liabilities |
| 12.74M | 11.78M | 13.21M | 13.73M | 13.63M | 7.68M | Stockholders Equity |
| 13.02M | 14.16M | 16.86M | 21.70M | 25.51M | 19.90M |
| Cash Flow | Free Cash Flow | ||||
| 123.70K | -1.85M | 185.15K | -5.20M | 236.13K | 2.80M | Operating Cash Flow |
| 147.65K | -1.61M | 372.00K | -4.88M | 383.00K | 3.09M | Investing Cash Flow |
| -23.68K | -243.29K | -187.00K | -319.00K | 1.53M | -292.36K | Financing Cash Flow |
| 162.54K | 1.84M | -332.71K | -350.00K | 2.02M | -737.08K |
Dynatronics Technical Analysis
Negative
0.11
Price Trends
0.13
Negative
0.13
Negative
0.16
Negative
Market Momentum
>-0.01
Negative
47.91
Neutral
44.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DYNT, the sentiment is Negative. The current price of 0.11 is below the 20-day moving average (MA) of 0.11, below the 50-day MA of 0.13, and below the 200-day MA of 0.16, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.91 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DYNT.
Dynatronics Risk Analysis
Dynatronics disclosed 36 risk factors in its most recent earnings report. Dynatronics reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Dynatronics Peers Comparison
Overall Rating
UnderperformOutperform
Sector (48)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $206.99M | 31.99 | 16.11% | ― | 15.35% | 71.35% | |
72 Outperform | $347.39M | 7.43 | 27.04% | ― | -17.44% | 73.71% | |
56 Neutral | $1.25B | ― | -33.30% | ― | 25.74% | 57.18% | |
55 Neutral | $74.00M | ― | -63.82% | ― | -9.49% | 39.20% | |
48 Neutral | $6.86B | 1.11 | -50.22% | 2.47% | 16.71% | 1.53% | |
46 Neutral | $933.89K | ― | -17.49% | ― | -14.91% | 49.03% |
* Healthcare Sector Average
Performance Comparison
DYNT
Dynatronics
0.11
-0.32
-74.42%
ELMD
Electromed
24.15
8.72
56.51%
TNDM
Tandem Diabetes Care
18.89
-15.37
-44.86%
SMLR
Semler Scientific
37.03
8.49
29.75%
MLSS
Milestone Scientific
0.99
0.36
57.14%
Dynatronics Earnings Call Summary
Earnings Call Date: Feb 6, 2025 | % Change Since: -21.43% | Next Earnings Date: May 8, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted successful cost reduction efforts and new product launches, which contributed to a decrease in net loss. However, the company faced challenges with decreased net sales and uncertainty regarding new product revenue. The lowered revenue guidance reflects ongoing challenges in demand and customer relationships.Highlights
Cost Reduction and Profitability Improvement
Operating expenses reduced by $3.7 million year-to-date, maintaining gross margin rates year-over-year.
New Product Introductions
Launched three new Hausmann product lines (Timber, Titan Premier, and Forged) with positive customer feedback and strong inventory positions.
Decrease in Net Loss
Net loss reduced to $0.7 million in Q3 FY 2024 from $1.2 million in Q3 FY 2023.
Decrease in SG&A Expenses
Selling, general, and administrative expenses decreased by $1 million or 30% compared to the previous year.
Lowlights
Decline in Net Sales
Net sales decreased from $9.2 million in Q3 FY 2023 to $7.7 million in Q3 FY 2024 due to changes in private label relationships and decreased demand in orthopedic soft bracing.
Uncertainty in Revenue from New Products
Too early to estimate revenue contribution from new product lines, indicating potential revenue uncertainty.
Reduced Revenue Guidance
Estimated net revenues for FY 2024 are $32.5 million to $34 million, reflecting slower demand and changes in customer relationships.
Company Guidance
In the third quarter earnings call for fiscal year 2024, Dynatronics provided guidance indicating that net revenues are projected to range between $32.5 million and $34 million due to slower demand in the rehabilitation sector and changes in private label customer relationships. The company did not provide gross margin guidance, citing a need for improved business stabilization before considering reintroducing such forecasts. Selling, general, and administrative expenses (SG&A) are anticipated to be between 30% and 32% of net sales for the fiscal year. The company's focus remains on strengthening customer relationships and enhancing operating profitability and financial flexibility.Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.